These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26928949)

  • 21. Involvement of CYP2E1-ROS-CD36/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro.
    Ma L; Wang Y; Chen X; Zhao L; Guo Y
    Toxicology; 2020 Dec; 445():152585. PubMed ID: 33007364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.
    Zhou J; Febbraio M; Wada T; Zhai Y; Kuruba R; He J; Lee JH; Khadem S; Ren S; Li S; Silverstein RL; Xie W
    Gastroenterology; 2008 Feb; 134(2):556-67. PubMed ID: 18242221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway.
    Zhang C; Luo X; Chen J; Zhou B; Yang M; Liu R; Liu D; Gu HF; Zhu Z; Zheng H; Li L; Yang G
    Diabetes; 2019 Oct; 68(10):1902-1914. PubMed ID: 31292134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic Overexpression of CD36 Improves Glycogen Homeostasis and Attenuates High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance.
    Garbacz WG; Lu P; Miller TM; Poloyac SM; Eyre NS; Mayrhofer G; Xu M; Ren S; Xie W
    Mol Cell Biol; 2016 Nov; 36(21):2715-2727. PubMed ID: 27528620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of hepatic CD36 via glucocorticoid receptor activation contributes to dexamethasone-induced liver lipid metabolism disorder in mice.
    Chen M; Bai M; Yi Y; Lu S; Luo J; Li P; Zhang H; Jiang H; Zhou H
    Toxicol Lett; 2022 Jun; 363():1-10. PubMed ID: 35589016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor.
    Hoang-Yen Tran D; Hoang-Ngoc Tran D; Mattai SA; Sallam T; Ortiz C; Lee EC; Robbins L; Ho S; Lee JE; Fisseha E; Shieh C; Sideri A; Shih DQ; Fleshner P; McGovern DP; Vu M; Hing TC; Bakirtzi K; Cheng M; Su B; Law I; Karagiannides I; Targan SR; Gallo RL; Li Z; Koon HW
    Int J Obes (Lond); 2016 Sep; 40(9):1424-34. PubMed ID: 27163748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sesamin ameliorates nonalcoholic hepatic steatosis by inhibiting CD36-mediated hepatocyte lipid accumulation in vitro and in vivo.
    Bai YP; Zhang T; Hu ZY; Zhang Y; Wang DG; Zhou MY; Zhang Y; Zhang F; Kong X
    Biochem Pharmacol; 2024 Jun; 224():116240. PubMed ID: 38679210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.
    Moyer BJ; Rojas IY; Kerley-Hamilton JS; Hazlett HF; Nemani KV; Trask HW; West RJ; Lupien LE; Collins AJ; Ringelberg CS; Gimi B; Kinlaw WB; Tomlinson CR
    Toxicol Appl Pharmacol; 2016 Jun; 300():13-24. PubMed ID: 27020609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic Deficiency of GHR in Pigs leads to Hepatic Steatosis via Negative Regulation of AHR Signaling.
    Han Q; Chen H; Wang L; An Y; Hu X; Zhao Y; Zhang H; Zhang R
    Int J Biol Sci; 2021; 17(15):4108-4121. PubMed ID: 34803486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin improves hepatic steatosis via CD36 pathway.
    Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
    J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of aryl hydrocarbon receptor dissociates fatty liver from insulin resistance by inducing fibroblast growth factor 21.
    Lu P; Yan J; Liu K; Garbacz WG; Wang P; Xu M; Ma X; Xie W
    Hepatology; 2015 Jun; 61(6):1908-19. PubMed ID: 25614121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice.
    Wolf Greenstein A; Majumdar N; Yang P; Subbaiah PV; Kineman RD; Cordoba-Chacon J
    J Endocrinol; 2017 Jan; 232(1):107-121. PubMed ID: 27799461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2.
    Barroso E; Rodríguez-Rodríguez R; Zarei M; Pizarro-Degado J; Planavila A; Palomer X; Villarroya F; Vázquez-Carrera M
    Cell Commun Signal; 2020 Sep; 18(1):147. PubMed ID: 32912335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aryl hydrocarbon receptor deficiency protects mice from diet-induced adiposity and metabolic disorders through increased energy expenditure.
    Xu CX; Wang C; Zhang ZM; Jaeger CD; Krager SL; Bottum KM; Liu J; Liao DF; Tischkau SA
    Int J Obes (Lond); 2015 Aug; 39(8):1300-1309. PubMed ID: 25907315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance.
    Steneberg P; Sykaras AG; Backlund F; Straseviciene J; Söderström I; Edlund H
    J Biol Chem; 2015 Jul; 290(31):19034-43. PubMed ID: 26085100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homocysteine activates cAMP-response element binding protein in HepG2 through cAMP/PKA signaling pathway.
    Woo CW; Siow YL; O K
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1043-50. PubMed ID: 16497994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cluster of Differentiation 36 Deficiency Aggravates Macrophage Infiltration and Hepatic Inflammation by Upregulating Monocyte Chemotactic Protein-1 Expression of Hepatocytes Through Histone Deacetylase 2-Dependent Pathway.
    Zhong S; Zhao L; Wang Y; Zhang C; Liu J; Wang P; Zhou W; Yang P; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
    Antioxid Redox Signal; 2017 Aug; 27(4):201-214. PubMed ID: 27967209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapamycin-mediated CD36 translational suppression contributes to alleviation of hepatic steatosis.
    Wang C; Yan Y; Hu L; Zhao L; Yang P; Moorhead JF; Varghese Z; Chen Y; Ruan XZ
    Biochem Biophys Res Commun; 2014 Apr; 447(1):57-63. PubMed ID: 24685479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coordinate regulation of cytochrome P450 1a1 expression in mouse liver by the aryl hydrocarbon receptor and the beta-catenin pathway.
    Braeuning A; Köhle C; Buchmann A; Schwarz M
    Toxicol Sci; 2011 Jul; 122(1):16-25. PubMed ID: 21498875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.